Phenylketonuria is an inherited disease caused by mutations in the phenylalanine hydroxylase gene PAH. Different PAH pathogenic variants occur in different ethnic groups with various frequencies and the incidence of the disease itself varies from country to country. In the Caucasus region of Russia, some ethnoses are geographically and culturally isolated from each other. The tradition of monoethnic marriages may cause decreased genetic variability in those populations. In the Karachay-Cherkess Republic (Russia), the highest incidence of phenylketonuria in the world has been detected (1:850 newborns) in the region and 1:332 among the titular nation Karachays. Here, we showed that this phenomenon is due to the widespread prevalence of the p.Arg261* variant. Its allele frequency among Karachay patients with PKU was 68.4% and the carrier frequency in Karachays was 1:16 healthy individuals. PAH haplotype analysis showed a unique common origin. The founder haplotype and mutation “age” were estimated by analyzing the linkage disequilibrium between p.Arg261* and extragenic short tandem repeat loci. The p.Arg261* variant occurred in the Karachays population 10.2 ± 2.7 generations ago (275 ± 73 years) and its spread occurred in parallel with the growth of the population.
Citation: Gundorova P, Zinchenko RA, Kuznetsova IA, Bliznetz EA, Stepanova AA, Polyakov AV (2018) Molecular-genetic causes for the high frequency of phenylketonuria in the population from the North Caucasus. PLoS ONE 13(8): e0201489. https://doi.org/10.1371/journal.pone.0201489
Editor: Wolfgang Arthofer, University of Innsbruck, AUSTRIA
Received: April 18, 2018; Accepted: July 15, 2018; Published: August 1, 2018
Copyright: © 2018 Gundorova et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: The research was partially funded with the grant of Russian Foundation for Basic Research 18-015-00090 (prof. Rena A. Zinchenko), http://www.rtbr.ru/rffi/eng. The research was partially funded with the internal sources of the FSBI "Research Centre for Medical Genetics" as a part of its scientific program. The research was conducted as a part of the state assignment. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
An increase in the concentration of phenylalanine (Phe) above the physiological norm is called hyperphenylalaninemia (HPA). The main type of HPA is phenylketonuria (PKU; OMIM #261600). Phenylketonuria is an autosomal recessive inherited error of metabolism resulting from a deficiency in phenylalanine hydroxylase (EC 126.96.36.199), an enzyme that catalyzes the hydroxylation of phenylalanine to tyrosine, the rate-limiting step in phenylalanine catabolism . Phenylketonuria is the most widespread aminoacidopathy in the world. The disease incidence is about 1:10000 worldwide and about 1:7000 in Russia . PKU is included in neonatal screening programs, which have been conducted in Russia since 1991. The highest PKU incidences were detected in Turkey at 1:4000  and Northern Ireland at 1:6500 . According to the clinical classification, classical PKU is characterized by a Phe concentration above 20 mg/dl, moderate PKU from 10–20 mg/dl, and mild HPA (mHPA) from 2–10 mg/dl . In this work, we use the term “mHPA” to emphasize the mild clinical diagnosis, while the term “PKU” is used to emphasize severe clinical features. “HPA” is used to describe the disease in general.
Since Russia is a multinational country, frequencies of monogenic diseases and different pathogenic variants can differ drastically among members of different ethnic groups . The Karachay-Cherkess Republic (KCR) is a region in the Southwest of the Russian Federation located in the north of the Caucasus Mountains. Karachay-Cherkessia has a population of 469,000 people, 43% of which live in cities. There are four major nationalities in the region: Karachays (41%), Russians (32%), Cherkessians (12%), and Abazins (8%). In two cities of the region, Karachaevsk and Cherkessk, representatives of these groups live together, but in the rural districts, ethnoses are largely isolated from each other. Monoethnic marriages between Karachays, according to epidemiological studies, account for 88.3% of marriages . In a small population, this situation can decrease genetic variability and change the frequency of homozygotes in the population; in particular, an increase in the frequencies of specific nosological forms is possible.
In Karachay-Cherkessia, patients with PKU and mHPA were identified and examined. Interestingly, the p.Arg261* (c.781C>T) PAH variant is very widespread among them. The allele frequency of p.Arg261* is 68.4% among PKU patients and 32.5% among mHPA patients [8, 9], so it is the predominant variant in this region. The presence of those genetic peculiarities in Karachay-Cherkessia presumably results from reproductive isolation and genetic drift in populations residing on this territory.
Materials and methods
DNA of 26 Karachays with a PKU diagnosis and a homozygous p.Arg261* genotype and DNA of 33 healthy relatives was used for haplotype analysis. The written informed consent for biological material collection, research, and publication of their results in the press was obtained. In case of children aged under 18, written informed consent was obtained from parents. Patients with PKU were selected through the regional medical-genetic counseling center. Ethics Committee of Federal State Budgetary Institution "Research Centre for Medical Genetics" had approved the study with decision of Protocol No. 2 at the meeting of March 15, 2017.
Expeditions for the purpose of collecting the material were carried out by the staff of the Laboratory of Genetic Epidemiology of the FSBI "Research Centre for Medical Genetics" in the period from 2013 to 2016. Patient selection was carried out through the regional medical-genetic counseling center of the Karachay-Cherkess Republic. As a result of the expedition work, families with a medical history of diseases "PKU" and "mHPA" were identified. For the haplotype analysis, only families with homozygous p.Arg261* genotype probands were selected.
Due to expedition work in the Karachaevsk and Cherkessk cities and six districts of the KCR, biological material was obtained from 676 healthy residents. The involvement of participants in the study was carried out through the regional medical-genetic counseling center of the KCR. Healthy residents were invited for the diagnosis of various inherited diseases such as HPA, cystic fibrosis, and hearing loss. Volunteers were further selected according to the following criteria: healthy for somatic and hereditary diseases; not related individuals; Karachay, Circassian, Abazin, or Nogay heritage up to the third generation; and natives of a particular region. Written informed consent was obtained for biological material collection, research, and publication of their results in the press. All volunteers were examined visually for the exclusion of hereditary diseases and syndromes by clinical genetic physicians and life-long anamnesis was collected. Study participants’ ages were between 18–40 years.
PAH variant detection
All PAH gene variants in the paper are related to the reference sequence NM_000277.1. A custom allele-specific MLPA panel with polyacrylamide electrophoresis visualization was created earlier based on the PKU mutation spectrum in the KCR . PAH variants p.Arg413Pro (c.1238G>C), p.Arg408Trp (c.1222C>T), p.Phe331Ser (c.992T>C), p.Arg261* (c.781C>T), p.Pro211Thr (c.631C>A), and p.Pro211Leu (c.632C>T) were studied in healthy Karachay-Cherkessia residents.
p.Arg261* chromosome haplotype investigation
Haplotype analysis was performed by studying seven intragenic single nucleotide polymorphism (SNP) loci (restriction fragment length polymorphism [RFLP] haplotypes), as well as intragenic tandem repeats regions via variable number tandem repeats (VNTRs) and short tandem repeats (STRs). SNPs were detected using the multiplex ligation-dependent probe amplification (MLPA) method visualized by acrylamide electrophoresis (S1 Appendix). The copy number analysis of the PAH gene intragenic tandem STRs and VNTRs was carried out by polymerase chain reaction (PCR) and Sanger sequencing [10, 11]. EcoRV restriction site analysis was not conducted due to technical limitations.
The analysis of the extragenic STR loci D12S1588, D12S1727, D12S78, D12S338, and D12S317 was carried out by PCR and polyacrylamide electrophoresis. The analysis was performed on the DNA of patients homozygous for the variant p.Arg261*, the DNA of all their relatives whose material was available for research, and also in the population sample of the Karachays.
To identify alleles associated with PKU, we analyzed polymorphic markers and determined the haplotypes of chromosomes bearing the p.Arg261* variant. When comparing the allele frequencies on chromosomes with a pathogenic variant and on population sample chromosomes, the χ2 criteria was used. For estimating the linkage disequilibrium of polymorphic markers in the patient group, we calculated δ  (1) where δ is a linkage disequilibrium, PD is the frequency of the associated allele among chromosomes with a pathogenic variant, and PN is the frequency of the same allele among normal chromosomes. The confidence interval for δ was estimated as follows : as δ is a function of the ratio of two independent random variables, the variance can be approximated as (2)
In formula (2), σ2pN = PN (1 –PN)/nN and σ2pD = PD (1 –PD)/nD, nN and nD−the sizes of samples of mutant and normal chromosomes. The corresponding 95% confidence interval for δ can be obtained as δ ± 2σδ, while σδ2 = var(δ) [13, 14].
The determination of mutation “age” is possible in cases where a mutation has spread as a result of the founder effect. The founder's chromosome bearing a new variant appears in the population by migration or de novo via mutation. Then, from generation to generation, the proportion of mutant chromosomes with the founder's haplotype decreases. (3) where g is the number of generations; Q is the proportion of mutant chromosomes without the founder's haplotype allele; PN is the frequency of the founder's allele in the population; and θ is the recombination fraction. At genetic distances less than 10 cM, θ is equal to the genetic distance in Morganids .
Definition of the estimated incidence of HPA and carrier frequency among healthy residents
Newborn screening data show the incidence of HPA in the KCR as 1:850 newborns . To calculate the PKU incidence in different ethnic groups, we performed DNA analysis among healthy residents. The custom PAH mutation-detecting panel was designed for DNA diagnostics for KCR residents. Six PAH variants can be detected by this method: p.Arg413Pro, p.Arg408Trp, p.Phe331Ser, p.Arg261*, p.Pro211Thr, and p.Pro211Leu. The overall allele frequency (calculated among patients) is 76.8% for KCR residents in general and 81.4% for Karachays . Carrier frequency and disease incidence were calculated, taking into account the effectiveness of the method.
Healthy indigenous representatives of ethical groups were examined: 328 Karachays, 104 Circassians, 126 Abazins, and 118 Nogays. Thirty-eight carriers of PAH variants were identified among them (Table 1). The majority of carriers identified were among Karachays, and this is consistent with the data of PKU patients. The calculated carrier frequency was 1:9 healthy Karachays and PKU incidence was 1:332 Karachays. For a small population, this is a catastrophically high carrier frequency and monogenic disease incidence. The calculated PKU incidence for Circassians and Nogays was 1:6380 and 1:8213, respectively, which was similar to the mean value in Russia. The calculated PKU incidence for Abazins was 1:4162, which was above the average.
The p.Arg408Trp variant, which is predominant in Caucasians including Russians, was not found in Karachays at all, but it was found in Circassians, Nogays, and once in Abazins. The carrier frequency of p.Arg261* among Karachays was 1:16. It is obvious that the high incidence of PKU in the Karachay-Cherkess Republic is provided mainly by the high heterozygous carrier frequency of PAH gene variants among the Karachays, mainly by the p.Arg261* mutation.
Features of the major variant p.Arg261* spread among Karachays
The wide distribution of the variant p.Arg261* among Karachays suggests the presence of the founder effect. When a new allele occurs, there is complete linkage disequilibrium of this locus with the rest. As a result of recombination, this imbalance decreases from generation to generation. This effect could be used for determining the moment when variant occurred or the mutation “age” [16–18].
DNA samples of 26 patients with PKU that were p.Arg261* homozygous were analyzed using RFLP for PAH haplotypes , a historically established method for analyzing the origin of PAH variants. The same homozygous haplotype was identified in all p.Arg261* homozygous patients. The haplotype identified for the p.Arg261* variant was similar to 8, 10, or 41 PAH haplotypes: PvuIIa +, PvuIIb -, BglII -, XmnI -, MspI +, EcoRI +, AluI +, STR 240 bp, VNTR 7 monomers. Since identical alleles for all the markers investigated were identified on all studied chromosomes with the p.Arg261* variant, linkage disequilibrium was δ = 1, and the haplotype was linked to the variant.
An analysis of the linkage with polymorphic markers lying at different genetic distances from the gene can reveal the degree of the haplotype decay and the mutation “age”. A study of genotypes of chromosomes was carried out on five STR markers located near the PAH gene in two samples: 26 Karachays homozygous for p.Arg261* and 30 healthy Karachays who were not related to the PKU patients or p.Arg261* carriers. Five STR markers located in the interval of 5002 kb around the PAH gene with high heterozygosity were selected. The frequencies of the identified alleles are presented in S2 Appendix.
For each allele of all the markers studied, the value of the linkage disequilibrium δ was determined using the formula (1). Using the obtained data, the allelic composition of the “founder haplotype” was revealed. Since at the time when the variant occurs, a complete disequilibrium with the marker alleles is formed, the “founder haplotype”, and as a result of recombination this disequilibrium decays with time, at the present moment the alleles that have the maximum disequilibrium coincide with the “founder haplotype”. Therefore, in determining the ancestral alleles, the greatest positive values of δ were taken into account (Table 2). The most likely “founder haplotype” was D12S1588-D12S1727-D12S78-D12S338-D12S317: 5-8-8-1-16.
Data shown in Table 2 show that the value of the linkage disequilibrium decreased with increasing distance from the PAH gene. This pattern is typical for populations in which the distribution of the allele occurred as a result of the founder effect. High values of linkage disequilibrium were maintained at a rather large distance from the gene: 4.82 cM toward the centromere and 4.28 cM toward the telomeres. This may indicate a relatively low age of the founder effect in the studied population.
Haplotypes of chromosomes with the p.Arg261* variant are presented in Table 3. In heterozygous patients, haplotypes were determined using family analysis where DNA from parents and other relatives was available (families No. 13, 21, 29, 32, 36, 37, 39, 40, 47, 49, 66, 109, 110, 111, and 201). In cases where it was not possible to determine on which chromosome one or another allele is located, the variants were determined through a fractional line (families No. 53 and 64).
The presence of a repeating haplotype in chromosomes with p.Arg261* confirmed the assumption that the variant was widely spread among the Karachays as a result of the founder effect. Calculation of the p.Arg261* mutation “age” was carried out according to formula (2) for markers D12S1588, D12S1727, and D12S317. For markers D12S78 and D12S338, the value of linkage disequilibrium with the confidence interval includes the value of δ = 1, that is, a small number of recombination events are detected for these markers, and they are actually still linked to the variant. For this reason, calculating the mutation “age” by markers D12S78 and D12S338 would be invalid.
The calculated mutation “age” for markers D12S1588, D12S1727, and D12S317 is presented in Table 2. The average value of the generations passed since the beginning of the variant spread was g = 10.2 ± 2.7 generations. The average age of one generation is calculated as the average value of the period from the birth of the parent to the birth of the first and last child. At the same time, the average age of a generation in females is always less than that in males. Studies conducted by anthropologists in primitive lifestyle populations determined the average age of one generation to be 30 years . According to a study conducted in the Karachay-Cherkess Republic, the average age of a generation is 26.98 years . Therefore, the time for which the accumulation of the p.Arg261* variant occurred in the Karachay people is 275 ± 73 years. The mean year of birth of patients was 2005, so the period of the p.Arg261* variant spreading beginning falls at the beginning of the 18th century (1730 ± 73 years).
PKU and mild HPA incidence
The ratio of the identified patients with PKU and mild HPA is 54% and 46%, respectively, as determined by newborn screening data. Patients from Russia usually have mild HPA in less than 10% of cases. On one hand, such patients do not need dietary treatment and can lead a lifestyle that is close to that of healthy people. On the other hand, for an individual having two pathogenic variants in the PAH gene in a marriage between PAH pathogenic variant carriers, the probability of producing an affected offspring is 50% and the probability of a healthy carrier is 50%. In this case, the affected offspring may in turn have a severe clinical form of the disease. Based on these considerations, DNA diagnosis for patients with "mild HPA" should be observed by pediatricians and geneticists, and mutation carrier status should be determined in their future spouses with the subsequent possibility of prenatal DNA diagnostics. In families containing individuals with HPA, detailed explanations on the possible future pregnancies of females with HPA and the associated risks of maternal PKU should be provided.
R261* haplotype origin
According to the literature, haplotype 3 in a German family and an incomplete haplotype in the Turkish family (MspI +, XmnI-) were described for the pathogenic variant p.Arg261* . These alleles for the Turkish family coincide with those of the Karachays, but the data are insufficient to confirm the similarity of haplotypes. In Norway, the p.Arg261* variant has been detected on chromosomes with haplotype 1 , in Italy with haplotypes 1 and 4 [22, 23], and in Portugal with haplotype 4 . Authors from Japan, who first described the variant p.Arg261*, identified the association of this variant with haplotype 2 . In Iran, where the allele frequency of variant p.Arg261* is 4.9%, PAH mini-haplotypes have been analyzed (8/230) , and they did not match those of the Karachays. Nevertheless, it is obvious that the variant R261* has a common origin in the Karachays individuals studied.
Time of p.Arg261* occurrence
Estimation of population growth parameters of Karachay people was carried out according to the dynamics of the Karachay population in the period from 1795 to 2010 . The growth graph is shown in Fig 1. Using Microsoft Excel, exponential dependence was approximated with an approximate accuracy value of R2 = 0.934. The specific rate of population growth based on the graph is d = 0.0158. When calculating the correction g0 for a growing population, according to Labuda , g0 < 0 was obtained for all markers. Since the value of d characterizes the slope of the exponent and actually represents the growth rate of the isolated population size, in our case it can be said that the number of Karachays, although increasing exponentially, increased very slowly. The Karachay population cannot be characterized as rapidly growing, which is due to the apparently high resistance of the environment. Thus, we do not observe the effect of slowing down the genetic clock. The correction g0 turned out to be inapplicable and was not needed to calculate the mutation “age” in the Karachay population.
The dots indicate the population numbers of the Karachay population . The curve is the approximation of exponential dependence on the graph of abundance versus time. The point of p.Arg261* origin is marked by an arrow; the error interval is in a square.
According to the literature, the first mention of Karachays occurred in the 12th century. Until 1795, the population did not increase and was within 200 families. The growth phase began at the end of the 18th century, as shown in Fig 1. Given the estimated p.Arg261* mutation “age”, it can be assumed that the beginning of the variant distribution coincided with the onset of population growth in the Karachay population. As a result of the described processes, the investigated pathogenic variant spread widely among the Karachays population (1:16 healthy Karachays) in a relatively short time interval of 250–300 years.
The DNA study of healthy Karachay-Cherkessia residents for the presence of frequent PAH pathogenic variants showed that the high incidence of HPA is caused by a significant frequency of PAH gene variants among Karachays. Among healthy Karachays, 1 in 16 is a carrier of the variant p.Arg261*, and 1 in 9 is a carrier of any variant of the PAH gene. The estimated incidence of all forms of the PAH-dependent HPA among Karachays is 1 in 332, and this the highest incidence reported to date. Thus, while Karachays constitute only 41% of the population of Karachay-Cherkessia, the wide distribution of PKU in this ethnic group accounts for the high incidence of PKU in the republic as a whole. The relatively high total frequency of mild PAH variants and the consequent high proportion of mild clinical forms of the disease (46% of patients identified by neonatal screening have mild HPA) probably played an important role in the process of accumulation of pathogenic variants among a healthy population.
The widespread distribution of p.Arg261* among Karachays suggested the presence of the founder effect. The study of PAH gene RFLP haplotypes on p.Arg261* chromosomes showed a common origin. The revealed haplotype, however, differs from all the described haplotypes for this variant, which suggested its independent origin. Investigation of the areas of tandem repeats in areas flanking the PAH gene made it possible to determine the disequilibrium in the linkage of these regions with the p.Arg261* variant and to calculate the time of its spread among the Karachays. The age of the mutation was g = 10.2 ± 2.7 generations or 275 ± 73 years. The variant p.Arg261* began to spread approximately 250–300 years ago in the population in the period corresponding to the beginning of exponential population growth.
S2 Appendix. Allelic frequencies of flanking PAH gene STR markers on chromosomes with the mutation R261* (52 chromosomes) and among healthy Karachays (60 chromosomes).
N–wild type alleles; R261*—R261* mutation carrying alleles; predominant alleles are marked in bold.
The authors are grateful for the participation of all patients in this study. We would also like to thank clinical genetic specialists from Karachay-Cherkessia for their cooperation.
- 1. Zurfluh MR, Zschocke J, Lindner M, Feillet F, Chery C, Burlina A, et al. Molecular genetics of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Human mutation. 2008 Jan;29(1):167–75. pmid:17935162
- 2. Novikov PV, Khodunova AA. The first results of extended newborn screening for hereditary metabolic diseases in the Russian Federation. Rossiyskiy Vestnik Perinatologii i Pediatrii. 2012;57(5):5–12 [InRuss].
- 3. Ozalp I, Coskun T, Tokatli A, Kalkanoglu HS, Dursun A, Tokol S, et al. Newborn PKU screening in Turkey: at present and organization for future. Turk J Pediatr. 2001 Apr-Jun;43(2):97–101. pmid:11432505
- 4. Zschocke J, Mallory JP, Eiken HG, Nevin NC. Phenylketonuria and the peoples of Northern Ireland. Hum Genet. 1997 Aug;100(2):189–94. pmid:9254847
- 5. Bliznetz EA, Tverskaya SM, Zinchenko RA, Abrukova AV, Savaskina EN, Nikulin MV, et al. Genetic analysis of autosomal recessive osteopetrosis in Chuvashiya: the unique splice site mutation in TCIRG1 gene spread by the founder effect. Eur J Hum Genet. 2009 May;17(5):664–72. pmid:19172990
- 6. Blau N, Shen N, Carducci C. Molecular genetics and diagnosis of phenylketonuria: state of the art. Expert Rev Mol Diagn. 2014 Jul;14(6):655–71. pmid:24882081
- 7. El'chinova GI, Shakmanov MM, Revazova YA, Ivanov AV, Rusakova AV, Zinchenko RA. Ethnic Marriage Assortativeness and Intensity of Metisation of Karachays. Russian Journal of Genetics. 2015 Aug;51(8):941–5.
- 8. Gundorova P, Stepanova AA, Makaov AK, Zinchenko RA, Polyakov AV. The Spectrum of Mutations in the PAH Gene in Patients with Hyperphenylalaninemia from the Karachay-Cherkess Republic. Russian Journal of Genetics. 2017;53(8):849–53.
- 9. Gundorova P, Stepanova AA, Makaov AK, Zinchenko RA, Abaychanova ZM, Polyakov AV. Mutation spectrum of the PAH gene in phenylketonuria patients in the Karachay-Cherkess Republic (Russia). Russian Journal of Genetics. 2016;52(12):1448–57.
- 10. Goltsov AA, Eisensmith RC, Konecki DS, Lichter-Konecki U, Woo SL. Associations between mutations and a VNTR in the human phenylalanine hydroxylase gene. Am J Hum Genet. 1992 Sep;51(3):627–36. pmid:1353941
- 11. Goltsov AA, Eisensmith RC, Naughton ER, Jin L, Chakraborty R, Woo SL. A single polymorphic STR system in the human phenylalanine hydroxylase gene permits rapid prenatal diagnosis and carrier screening for phenylketonuria. Hum Mol Genet. 1993 May;2(5):577–81. pmid:8100164
- 12. Bengtsson BO, Thomson G. Measuring the strength of associations between HLA antigens and diseases. Tissue Antigens. 1981 Nov;18(5):356–63. pmid:7344182
- 13. Diaz GA, Gelb BD, Risch N, Nygaard TG, Frisch A, Cohen IJ, et al. Gaucher disease: the origins of the Ashkenazi Jewish N370S and 84GG acid beta-glucosidase mutations. Am J Hum Genet. 2000 Jun;66(6):1821–32. pmid:10777718
- 14. Durst R, Colombo R, Shpitzen S, Avi LB, Friedlander Y, Wexler R, et al. Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: positive selection is not always necessary to account for disease incidence among Ashkenazi Jews. Am J Hum Genet. 2001 May;68(5):1172–88. pmid:11309683
- 15. Risch N, de Leon D, Ozelius L, Kramer P, Almasy L, Singer B, et al. Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population. Nat Genet. 1995 Feb;9(2):152–9. pmid:7719342
- 16. Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics. 1995 Sep 20;29(2):311–22. pmid:8666377
- 17. Mueller JC. Linkage disequilibrium for different scales and applications. Brief Bioinform. 2004 Dec;5(4):355–64. pmid:15606972
- 18. Pritchard JK, Przeworski M. Linkage disequilibrium in humans: models and data. Am J Hum Genet. 2001 Jul;69(1):1–14. pmid:11410837
- 19. Lidsky AS, Ledley FD, DiLella AG, Kwok SC, Daiger SP, Robson KJ, et al. Extensive restriction site polymorphism at the human phenylalanine hydroxylase locus and application in prenatal diagnosis of phenylketonuria. Am J Hum Genet. 1985 Jul;37(4):619–34. pmid:9556654
- 20. Dworniczak B, Kalaydjieva L, Aulehla-Scholz C, Ullrich K, Kremensky I, Radeva B, et al. Recurrent nonsense mutation in exon 7 of the phenylalanine hydroxylase gene. Hum Genet. 1991 Oct;87(6):731–3. pmid:1682234
- 21. Eiken HG, Knappskog PM, Boman H, Thune KS, Kaada G, Motzfeldt K, et al. Relative frequency, heterogeneity and geographic clustering of PKU mutations in Norway. Eur J Hum Genet. 1996;4(4):205–13. pmid:8875186
- 22. Dianzani I, Giannattasio S, de Sanctis L, Alliaudi C, Lattanzio P, Dionisi Vici C, et al. Characterization of phenylketonuria alleles in the Italian population. Eur J Hum Genet. 1995;3(5):294–302. pmid:8556304
- 23. Romano V, Cali F, Guldberg P, Guttler F, Indelicato A, Bosco P, et al. Association between haplotypes, hind III-VNTR alleles and mutations at the PAH locus in Sicily. Acta Paediatr Suppl. 1994 Dec;407:39–40. pmid:7766953
- 24. Rivera I, Leandro P, Lichter-Konecki U, Tavares de Almeida I, Lechner MC. Population genetics of hyperphenylalaninaemia resulting from phenylalanine hydroxylase deficiency in Portugal. J Med Genet. 1998 Apr;35(4):301–4. pmid:9598724
- 25. Shirahase W, Oya N, Shimada M. A new single base substitution in a Japanese phenylketonuria (PKU) patient. Brain Dev. 1991 Jul;13(4):283–4. pmid:1683521
- 26. Razipour M, Alavinejad E, Sajedi SZ, Talebi S, Entezam M, Mohajer N, et al. Genetic study of the PAH locus in the Iranian population: familial gene mutations and minihaplotypes. Metab Brain Dis. 2017 Oct;32(5):1685–91. pmid:28676969
- 27. Ediev DM. Demograficheskie poteri deportirovannyh narodov SSSR. Shamanov IM, editor. Stavropol': StGAU "AGRUS" 2003. Russian.
- 28. Labuda D, Zietkiewicz E, Labuda M. The genetic clock and the age of the founder effect in growing populations: a lesson from French Canadians and Ashkenazim. Am J Hum Genet. 1997 Sep;61(3):768–71. pmid:9326343